Colchicine inhibits the prothrombotic effects of oxLDL in human endothelial cells.

Abstract

BACKGROUND:

Tissue Factor (TF) plays a pivotal role in coronary thrombosis. Oxidized low-density lipoproteins (oxLDL) are crucial in development of atherosclerosclerosis. Moreover, oxLDL are known to induce TF expression on several cell types including endothelial cells. The lectin-type oxidized LDL receptor 1 (LOX-1) represent the oxLDL receptor. Colchicine is an anti-mitotic drug recently proven to have beneficial effects in cardiovascular disease via unknown mechanisms. Thus, we aim at investigating colchicine effects on TF expression in oxLDL stimulated human vascular endothelial cells (HUVEC). Some molecular mechanism(s) potentially involved were investigated.

METHODS:

HUVEC were pre-incubated with colchicine 10 μM for 1 h and then stimulated with oxLDL (50 μg/mL). TF gene (RT-PCR), protein (western blot), surface expression (FACS) and procoagulant activity (FXa generation assay) were measured. TF translocation to cell surface was investigated by immunofluorescence. NF-κB/IκB axis was examined by western blot analysis and translocation assay. Finally, LOX-1 expression was also investigated.

RESULTS:

Colchicine significantly reduced TF gene and protein expression as well as its procoagulant activity in oxLDL-treated HUVEC. These effects seem to be related mainly to action of colchicine on microtubules that, in turn, modulate TF trafficking in the cytoplasm, NF-κB/IκB pathway and LOX-1 expression.

CONCLUSIONS:

Data of the present study, although in vitro, indicate that one of the hypothetical mechanisms by which colchicine exert protective cardiovascular effects might be its ability to inhibit the pro-thrombotic activity of oxLDL.

• Authors: Giovanni Cimmino, Stefano Conte, Andrea Morello, Grazia Pellegrino, Laura Marra, Gaetano Calì, Paolo Golino, Plinio Cirillo
• Journal: Vascular pharmacology (Vascul Pharmacol) Vol. 137 Pg. 106822 (04 2021) ISSN: 1879-3649 [Electronic] United States
• PMID: 33232770 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2020 Elsevier Inc. All rights reserved.

Chemical References

• Fibrinolytic Agents
• I-kappa B Proteins
• Lipoproteins, LDL
• NF-kappa B
• OLR1 protein, human
• Scavenger Receptors, Class E
• oxidized low density lipoprotein
• Thromboplastin
• Factor Xa
• Colchicine

Topics

• Blood Coagulation (drug effects)
• Cells, Cultured
• Colchicine (pharmacology)
• Factor Xa (metabolism)
• Fibrinolytic Agents (pharmacology)
• Human Umbilical Vein Endothelial Cells (drug effects, metabolism)
• Humans
• I-kappa B Proteins (metabolism)
• Lipoproteins, LDL (pharmacology)
• NF-kappa B (metabolism)
• Scavenger Receptors, Class E (genetics, metabolism)
• Thromboplastin (genetics, metabolism)